Skip to Main Content Go to Sitemap

Melinda Solomon

Title:
Staff Respirologist, Divison of Respiratory Medicine
Designations:
MD, FRCPC
Email:
Melinda.solomon@sickkids.ca
Alternate Contact Name:
Roseanne Cloonan
Alternate Phone:
416-813-6248
Alternate Email:
roseanne.cloonan@sickkids.ca
U of T Positions:
Professor, Department of Paediatrics
Chair Positions:
Vice-Chair, Royal College of Physicians & Surgeons Respiratory Medicine Subspecialty Committee

Hospital Positions

Medical Director
Lung Transplant Program
Division of Respiratory Medicine  
 

Director
Cystic Fibrosis Clinic

Division of Respiratory Medicine  

Director
Training Program
 
Division of Respiratory Medicine  

Biography

Dr. Melinda Solomon is a Staff Respirologist in the Division of Respiratory Medicine at The Hospital for Sick Children (SickKids) and Professor of Paediatrics at the University of Toronto. She completed medical school at the University of Toronto and her paediatric residency training and Respiratory Medicine Fellowship at SickKids. She then completed Lung Transplant Training at the Children’s Hospital of Pittsburgh and Toronto General Hospital. She then joined the faculty at SickKids. Subsequently she completed a master’s of science in Community Health - Health Professionals Teacher Education.

She has been the Medical Director of the Paediatric Lung Transplant Program since 2003 and the Director of Cystic Fibrosis clinic at SickKids since 2005.

In her role as an educator she has been the training program director for respiratory medicine since 2000; teaching and mentoring students and health care professionals at all levels of training.

Research

Dr. Solomon’s research endeavors have been aligned with her clinical expertise, focusing on paediatric lung transplantation and Cystic Fibrosis (CF). As Director of the CF clinic, she is actively involved in several CF clinical trials evaluating new therapeutic strategies. In addition, she collaborates on various studies and guideline documents pertaining to CF and lung transplantation to advance clinical care

Education and experience

  • 2010–Present: Associate Staff Physician, Department of Paediatrics, Thunder Bay Regional Health Sciences Centre, Thunder Bay, ON, Canada (Cystic Fibrosis Satellite Clinic)
  • 2008–2011: Masters of Science in Community Health - Health Professionals Teacher Education; University of Toronto, Toronto, ON, Canada
  • 2006–2008: Education Scholars Program University of Toronto, Toronto, ON, Canada
  • 2000: Paediatric Lung Transplantation training Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA
  • Jul 1998 – Nov 1999: Chief Fellow- Paediatric Respirology. University of Toronto, The Hospital for Sick Children, Toronto, ON, Canada
  • Jul 1997 – Nov 1999: Paediatric Respirology Program Director: Dr. J Reisman. University of Toronto, The Hospital for Sick Children, Toronto, ON, Canada
  • Jul 1996 – Jun 1997: Associate Chief Resident in Paediatrics University of Toronto, The Hospital for Sick Children, Toronto, ON, Canada
  • Jul 1993 – Jun 1997: Paediatric Residency University of Toronto, The Hospital for Sick Children, Toronto, ON, Canada
  • Jun 1991 – Jun 1992: Student Internship. University of Toronto, Hugh MacMillan Rehabilitation Centre, Toronto, ON, Canada
  • 1989–1993: Doctor of Medicine, MD, University of Toronto, Toronto, ON, Canada
  • 1999–Present: Staff Physician, Division of Respiratory Medicine, The Hospital for Sick Children, Toronto, ON, Canada

Achievements

  • 2012: Harry Bain Award for Excellence in Academic Teaching. The Hospital for Sick Children, Toronto, ON, Canada.
  • 2011: POWER Teacher Award, Department of Paediatrics. The Hospital for Sick Children, Toronto, ON, Canada.
  • 2005: R.H.A. Haslam Award for Excellence in Pre-clerkship Teaching (runner up). The Hospital for Sick Children Toronto, ON, Canada.
  • 2005: PERLS (Paediatric Education Resident Lecture Series) Teaching Award. The Hospital for Sick Children, Toronto, ON, Canada.

Publications

  1. (SRA) Grasemann H, Ratjen F, Solomon M. Aquagenic wrinkling of palms in cystic fibrosis. N Engl J Med 2013 December 12;369(24):2362-3. PMID: 24328486
  2. (SRA) Grasemann H, de Perrot M, Bendiak G, Cox P, van Arsdell G, Keshavjee S, Solomon M. ABO-incompatible lung transplantation in an infant. American Journal of Transplantation. 2012 March;12(3):779-81. PMID: 2215204
  3. (SRA) Kalnins D, Pencharz PB, Grasemann H, Solomon M. Energy Expenditure and Nutritional Status in in pediatric patients before and after lung transplantation. J Pediatr. 2013 Nov;163(5):1500-2. doi: 10.1016/j.jpeds.2013.05.063. Epub 2013 Jul 17. PMID: 23870785
  4. (SRA) Grasemann H, Kritzinger F, Dipchand A, Hebert D, Solomon M. Nasal nitric oxide is reduced in children after solid-organ transplantation. Journal of Heart and Lung Transplantation. 2011 January; 30(1): 108-109. PMID: 20934886
  5. (Coll) Ooi CY, Castellani C, Keenan K, Avolio J, Volpi S, Boland M, Kovesi T, Bjornson C, Chilvers MA, Morgan L, van Wylick R, Kent S, Price A, Solomon M, Tam K, Taylor L, Malitt KA, Ratjen F, Durie PR, Gonska T. Inconclusive diagnosis of Cystic Fibrosis after newborn screening. Pediatrics. 2015 June;135(6): e1377-85. PMID: 25963003

See a full list of Melinda Solomon's publications

  • 2016–2020: Co-Investigator. Randomized controlled trial of prednisone in CF pulmonary exacerbations (PIPE Study). Cystic Fibrosis Canada. Principal Investigator: V. Waters. $377,654 CAD. 
  • 2016–2019: Co-Investigator. LCI to monitor treatment response for pulmonary exacerbations. Cystic Fibrosis Canada. $257,264 CAD 
  • 2016–2019: Co-Investigator. Tracking CF lung disease through the early years: Utility of the LCI. Cystic Fibrosis Foundation Therapeutics. $860,000 USD 
  • 2015–2018: Co-Investigator. SHIP (Saline Hypertonic in Preschoolers Study). Cystic Fibrosis Foundation Therapeutics Inc. Principal Investigator: F. Ratjen.$170,931 USD 
  • 2014–2018: Co-Investigator. SHIP (Saline Hypertonic in Preschoolers Study). Cystic Fibrosis Foundation Therapeutics Inc. Principal Investigator: F. Ratjen. $2,058,043 USD. 
  • 2014–2018: Co-Investigator. Long-Term Survival in Childhood Solid Organ Transplants. Canadian Institutes of Health Research (CIHR). Principal Investigator: R. Parekh. $514,979 CAD. 
  • 2008–2020: Site Co-Investigator Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic Fibrosis (PUSH). Summary for CF Care Providers. Cystic Fibrosis Foundation, National Institute of Health (NIH) Principal Investigator: S.Ling. $75,000USD annually 

Relevant pages

Divison of Respiratory Medicine

We are a modern tertiary service and diagnostic testing centre for the multidisciplinary care of a wide range of lung conditions.

CF Centre

Driving research discovery and new therapies, care, and education for cystic fibrosis to benefit children worldwide.

TRMC

Canada's most research-intensive paediatric transplant program, and the largest centre dedicated to transplant care.

Back to Top